Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/05/2015 | WO2015031815A2 Antibodies and assays for detection of folate receptor 1 |
03/05/2015 | WO2015031693A1 Engineered anti-dll3 conjugates and methods of use |
03/05/2015 | WO2015031681A1 Micronized placental compositions comprising a chelator |
03/05/2015 | WO2015031673A2 Cns-targeted conjugates having modified fc regions and methods of use thereof |
03/05/2015 | WO2015031645A1 Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv |
03/05/2015 | WO2015031552A1 Estradiol containing transdermal drug delivery systems and compositions |
03/05/2015 | WO2015031425A1 Compound of glycosaminoglycan and its preparation method as well as application |
03/05/2015 | WO2015031412A1 Testosterone booster transdermal compositions |
03/05/2015 | WO2015031396A1 Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses |
03/05/2015 | WO2015031284A1 Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s) |
03/05/2015 | WO2015031244A1 A process to produce an aqueous dispersion, an aqueous dispersion produced thereby and a coating composition comprising the aqueous dispersion |
03/05/2015 | WO2015031198A2 Bendamustine pharmaceutical compositions |
03/05/2015 | WO2015031059A1 Ph-sensitive peptides and their nanoparticles for drug delivery |
03/05/2015 | WO2015029926A1 Ophthalmological composition |
03/05/2015 | WO2015029924A1 Ophthalmological composition |
03/05/2015 | WO2015029717A1 Ophthalmic solution |
03/05/2015 | WO2015028966A2 Amino diacids containing peptide modifiers |
03/05/2015 | WO2015028920A1 Ionic gelation on solids |
03/05/2015 | WO2015028850A1 Novel cytotoxic agents for conjugation of drugs to cell binding molecule |
03/05/2015 | WO2015028637A1 Novel drug formulation |
03/05/2015 | WO2015028172A1 Compound of glycosaminoglycan, preparation method and use thereof |
03/05/2015 | WO2015027342A1 Microgel compositions for delivery of substances to the brain |
03/05/2015 | WO2015027322A1 Methods and compositions for treatment of cartilage and disc tissue pathologies |
03/05/2015 | WO2014165093A9 Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto |
03/05/2015 | US20150065711 Discrete PEG Constructs |
03/05/2015 | US20150065685 Laser-actuated therapeutic nanoparticles |
03/05/2015 | US20150065670 Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents |
03/05/2015 | US20150065586 Amino acid derivatives and absorbable polymers therefrom |
03/05/2015 | US20150065582 Orally Dissolving Formulations of Memantine |
03/05/2015 | US20150065570 Agent for inducing the synthesis of heat-shock proteins in human and animal cells |
03/05/2015 | US20150065558 Glycoconjugates of RNA Interference Agents |
03/05/2015 | US20150065553 Stabilized statin formulations |
03/05/2015 | US20150065549 Bendamustine Pharmaceutical Compositions |
03/05/2015 | US20150065548 Composition comprising an organic diluent and a cellulose ether |
03/05/2015 | US20150065547 Esterified cellulose ethers having a specific substituent distribution |
03/05/2015 | US20150065536 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof |
03/05/2015 | US20150065491 Administration of benzodiazepine compositions |
03/05/2015 | US20150065479 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor |
03/05/2015 | US20150065474 Dexamethasone formulations in a biodegradable material |
03/05/2015 | US20150065467 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
03/05/2015 | US20150065462 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease |
03/05/2015 | US20150065461 Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint |
03/05/2015 | US20150065453 Combination of an oxidant and a photoactivator for the healing of wounds |
03/05/2015 | US20150065450 Compound of glycosaminoglycan and its preparation method as well as application |
03/05/2015 | US20150065443 Embelin-based delivery system for water-insoluble active agents |
03/05/2015 | US20150065442 Reducible self-assembled micelle drug delivery systems |
03/05/2015 | US20150065426 Testosterone Booster Transdermal Compositions |
03/05/2015 | US20150065423 Rapid acting injectable formulations |
03/05/2015 | US20150065420 Vitamin d-ghrelin conjugates |
03/05/2015 | US20150064283 Pharmaceutical compositions for parenteral administration |
03/05/2015 | US20150064282 Use of neu1 sialidase inhibitors in the treatment of cancer |
03/05/2015 | US20150064275 Compositions for improved tissue oxygenation by peritoneal ventilation |
03/05/2015 | US20150064274 Micronized placental compositions comprising a chelator |
03/05/2015 | US20150064268 Nanoparticles for stimulating elastogenesis |
03/05/2015 | US20150064266 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
03/05/2015 | US20150064265 Vehicles for Controlled Delivery of Different Pharmaceutical Agents |
03/05/2015 | US20150064259 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
03/05/2015 | US20150064258 Diclofenac formulations and methods of use |
03/05/2015 | US20150064255 Nanostructures for treating cancers and other conditions |
03/05/2015 | US20150064252 Solid dispersion formulation of an antiviral compound |
03/05/2015 | US20150064248 Abuse resistant forms of extended release hydromorphone, method of use and method of making |
03/05/2015 | US20150064247 Abuse resistant forms of immediate release hydrocodone, method of use and method of making |
03/05/2015 | US20150064243 Pharmaceutical compositions and dosage forms for admininistration of hydrophobic drugs |
03/05/2015 | US20150064242 Trialkyl cationic lipids and methods of use thereof |
03/05/2015 | US20150064238 Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke |
03/05/2015 | US20150064233 Lipid-coated nucleic acid nanostructures of defined shape |
03/05/2015 | US20150064231 Oral film containing opiate enteric-release beads |
03/05/2015 | US20150064230 Sustained release delivery of one or more agents |
03/05/2015 | US20150064212 Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction |
03/05/2015 | US20150064205 Enhancement of pathogen-specific memory th17 cell responses |
03/05/2015 | US20150064190 Antibodies to tumor endothelial marker 7r |
03/05/2015 | US20150064181 Antisense conjugates for decreasing expression of dmpk |
03/05/2015 | US20150064166 Lyophilized Preparation of Botulinum Toxin |
03/05/2015 | US20150064164 Tissue disruption treatment and composition for use thereof |
03/05/2015 | US20150064155 Methods for treatment of cervical insufficiency |
03/05/2015 | US20150064130 Protein-polymer-drug conjugates |
03/05/2015 | US20150064124 Personal care formulations containing alkyl ketal esters and methods of manufacture |
03/05/2015 | US20150064118 Lipid depot formulations |
03/05/2015 | US20150064117 Novel polymorphs of rebaudioside c and methods for making and using the same |
03/05/2015 | US20150064116 Multilayered magnetic micelle compositions and methods for their use |
03/05/2015 | US20150064110 Crosslinked polysaccharide beads comprising an imaging agent |
03/05/2015 | US20150064106 Biodegradable Polyphosphazenes Containing Pyrrolidone Side Groups |
03/05/2015 | DE102013109514A1 Reduktion der Zelltoxizität von Bakteriostatika mittels Farbstoffen Reduction of cell toxicity of antimicrobials using dyes |
03/04/2015 | EP2842986A1 Method for producing starch granules, and orally disintegrating tablet |
03/04/2015 | EP2842967A1 Pegylated amyloid beta fab |
03/04/2015 | EP2842942A1 Trans-2-decenoic acid derivative and drug containing same |
03/04/2015 | EP2842576A1 Transglutaminase mediated conjugation of peptides |
03/04/2015 | EP2842575A1 Auristatin drug linker conjugates |
03/04/2015 | EP2842574A1 Sustained release carrier for drugs |
03/04/2015 | EP2842571A1 Antibodies directed to GPNMB and uses thereof |
03/04/2015 | EP2842570A1 Compositions and methods for the prevention and treatment of autoimmune conditions |
03/04/2015 | EP2842559A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
03/04/2015 | EP2842553A1 Analgesic |
03/04/2015 | EP2842549A1 Orally disintegrating tablet and method for producing same |
03/04/2015 | EP2842546A1 Unit structure-type pharmaceutical composition for nucleic acid delivery |
03/04/2015 | EP2842545A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof |
03/04/2015 | EP2841486A2 Polymeric nanoparticles and a process of preparation thereof |
03/04/2015 | EP2841112A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging |
03/04/2015 | EP2841111A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof |
03/04/2015 | EP2841110A1 A method for antigen delivery |